EligibleTrials

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

Recruiting · NCT07227532 · Interventional (participants receive a specific treatment) · Lead sponsor: Biosense Webster, Inc.

View the official record on ClinicalTrials.gov →
Atrial Fibrillation

Interventions studied

Pulsed Field Ablation by VARIPULSE Catheter with TRUPULSE Generator

What this trial is about

The purpose of this study is to evaluate the long-term safety and effectiveness of the FDA approved VARIPULSE catheter system for pulmonary vein isolation (PVI) in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF).

Who can take part

Age range
22 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

22 locations listed across 13 US states.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.